177Lu-Dotatate for midgut neuroendocrine tumours

被引：5
|
作者：
Burki, Talha Khan
机构：
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 02期
关键词：
D O I：
10.1016/S1470-2045(17)30042-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E74 / E74
页数：1
相关论文
共 50 条
  • [1] 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Matuchansky, Claude
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1391 - 1391
  • [2] Receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumours
    Bodei, L.
    Cremonesi, M.
    Grana, C.
    Bartolomei, M.
    Baio, S.
    Bufi, G.
    Fiorenza, M.
    Obenaus, E.
    Paganelli, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S214 - S214
  • [3] Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Strosberg, J.
    El-Haddad, G.
    Wolin, E.
    Hendifar, A.
    Yao, J.
    Chasen, B.
    Mittra, E.
    Kunz, P. L.
    Kulke, M. H.
    Jacene, H.
    Bushnell, D.
    O'Dorisio, T. M.
    Baum, R. P.
    Kulkarni, H. R.
    Caplin, M.
    Lebtahi, R.
    Hobday, T.
    Delpassand, E.
    Van Cutsem, E.
    Benson, A.
    Srirajaskanthan, R.
    Pavel, M.
    Mora, J.
    Berlin, J.
    Grande, E.
    Reed, N.
    Seregni, E.
    Oberg, K.
    Sierra, M. Lopera
    Santoro, P.
    Thevenet, T.
    Erion, J. L.
    Ruszniewski, P.
    Kwekkeboom, D.
    Krenning, E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02): : 125 - 135
  • [4] 177Lu-DOTATATE treatment in neuroendocrine tumours. A preliminary study
    Hervas, I.
    Bello, P.
    Falgas, M.
    del Olmo, M. I.
    Torres, I.
    Olivas, C.
    Vera, V.
    Olivan, P.
    Yepes, A. M.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (02): : 91 - 98
  • [5] Prognostic stratification for patients with neuroendocrine tumours receiving 177Lu-Dotatate
    Chen, Luohai
    Gnanasegaran, Gopinath
    Mandair, Dalvinder
    Toumpanakis, Christos
    Caplin, Martyn
    Navalkissoor, Shaunak
    [J]. ENDOCRINE-RELATED CANCER, 2022, 29 (02) : 111 - 120
  • [6] Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
    Strosberg, Jonathan R.
    Srirajaskanthan, Rajaventhan
    El-Haddad, Ghassan
    Wolin, Edward M.
    Chasen, Beth R.
    Kulke, Matthew H.
    Bushnell, David L.
    Caplin, Martyn E.
    Baum, Richard P.
    Hendifar, Andrew E.
    Oberg, Kjell
    Ruszniewski, Philippe
    Santoro, Paola
    Broberg, Per
    Leeuwenkamp, Oscar R.
    Krenning, Eric P.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (12): : 1712 - 1718
  • [7] Neuroendocrine Tumor Therapy: 177Lu-DOTATATE
    Mittra, Erik S.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (02) : 278 - 285
  • [8] Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
    Sundlov, Anna
    Sjogreen-Gleisner, Katarina
    Svensson, Johanna
    Ljungberg, Michael
    Olsson, Tomas
    Bernhardt, Peter
    Tennvall, Jan
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1480 - 1489
  • [9] 177Lu-DOTATATE Quantification for Patient Personalised Dosimetry in Therapy of Neuroendocrine Tumours
    Rodrigues, C.
    Ferreira, P.
    Oliveira, F. P. M.
    Silva, A.
    Peralta, L.
    Costa, D. C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S656 - S656
  • [10] Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
    Anna Sundlöv
    Katarina Sjögreen-Gleisner
    Johanna Svensson
    Michael Ljungberg
    Tomas Olsson
    Peter Bernhardt
    Jan Tennvall
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1480 - 1489
12345